Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers
Open Access
- 30 June 2020
- Vol. 9 (7), 1582
- https://doi.org/10.3390/cells9071582
Abstract
When breast cancer progresses to a metastatic stage, survival rates decline rapidly and it is considered incurable. Thus, deciphering the critical mechanisms of metastasis is of vital importance to develop new treatment options. We hypothesize that studying the proteins that are newly synthesized during the metastatic processes of migration and invasion will greatly enhance our understanding of breast cancer progression. We conducted a mass spectrometry screen following bioorthogonal noncanonical amino acid tagging to elucidate changes in the nascent proteome that occur during epidermal growth factor stimulation in migrating and invading cells. Annexin A2 was identified in this screen and subsequent examination of breast cancer cell lines revealed that Annexin A2 is specifically upregulated in estrogen receptor negative (ER-) cell lines. Furthermore, siRNA knockdown showed that Annexin A2 expression promotes the proliferation, wound healing and directional migration of breast cancer cells. In patients, Annexin A2 expression is increased in ER- breast cancer subtypes. Additionally, high Annexin A2 expression confers a higher probability of distant metastasis specifically for ER- patients. This work establishes a pivotal role of Annexin A2 in breast cancer progression and identifies Annexin A2 as a potential therapeutic target for the more aggressive and harder to treat ER- subtype.Funding Information
- Irish Research Council (GOIPG/2016/1547)
- Science Foundation Ireland (13/CDA/2228)
This publication has 100 references indexed in Scilit:
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Global quantification of mammalian gene expression controlNature, 2011
- The Role of Annexin A2 in Tumorigenesis and Cancer ProgressionCancer Microenvironment, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomesCancer, 2010
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- Illuminating the metastatic processNature Reviews Cancer, 2007
- Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT)Proceedings of the National Academy of Sciences of the United States of America, 2006
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002